Health care stocks were steady premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) unchanged.

Praxis Precision Medicines (PRAX) shares were up more than 11% after the company said the US Food and Drug Administration has granted Breakthrough Therapy Designation for ulixacaltamide to treat patients with Essential Tremor disorder.